GB1316069A - Methods and pharmaceutical compositions for inhibiting gluconeo genesis - Google Patents

Methods and pharmaceutical compositions for inhibiting gluconeo genesis

Info

Publication number
GB1316069A
GB1316069A GB1569172A GB1569172A GB1316069A GB 1316069 A GB1316069 A GB 1316069A GB 1569172 A GB1569172 A GB 1569172A GB 1569172 A GB1569172 A GB 1569172A GB 1316069 A GB1316069 A GB 1316069A
Authority
GB
United Kingdom
Prior art keywords
acid
inhibiting
methods
pharmaceutical compositions
thiol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1569172A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of GB1316069A publication Critical patent/GB1316069A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1569172A 1971-04-06 1972-04-05 Methods and pharmaceutical compositions for inhibiting gluconeo genesis Expired GB1316069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13183471A 1971-04-06 1971-04-06

Publications (1)

Publication Number Publication Date
GB1316069A true GB1316069A (en) 1973-05-09

Family

ID=22451218

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1569172A Expired GB1316069A (en) 1971-04-06 1972-04-05 Methods and pharmaceutical compositions for inhibiting gluconeo genesis

Country Status (8)

Country Link
AU (1) AU461338B2 (cg-RX-API-DMAC7.html)
BE (1) BE781416A (cg-RX-API-DMAC7.html)
DE (1) DE2216576A1 (cg-RX-API-DMAC7.html)
FR (1) FR2132398B1 (cg-RX-API-DMAC7.html)
GB (1) GB1316069A (cg-RX-API-DMAC7.html)
IL (1) IL39088A (cg-RX-API-DMAC7.html)
NL (1) NL7204458A (cg-RX-API-DMAC7.html)
ZA (1) ZA722084B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2245935A1 (de) 2009-05-02 2010-11-03 Bayer CropScience AG Herbizide Verbindungen auf Basis von N-Azinyl-N-pyridylsulfonyl-harnstoffen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639413A (en) * 1969-09-26 1972-02-01 Dow Chemical Co (thio- sulfinyl- and sulfonyl) containing pyridine compounds

Also Published As

Publication number Publication date
AU461338B2 (en) 1975-05-06
IL39088A0 (en) 1972-05-30
AU4075472A (en) 1973-10-11
ZA722084B (en) 1972-12-27
DE2216576A1 (de) 1972-10-19
FR2132398A1 (cg-RX-API-DMAC7.html) 1972-11-17
NL7204458A (cg-RX-API-DMAC7.html) 1972-10-10
IL39088A (en) 1975-08-31
BE781416A (fr) 1972-09-29
FR2132398B1 (cg-RX-API-DMAC7.html) 1975-12-26

Similar Documents

Publication Publication Date Title
IE36265L (en) 1,4-dihydropyridinedicarboxylic acid esters
GB1331405A (en) Esters their production and their medicinal use
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
GB1464324A (en) 1,4-dihydropyridines and ''ocesses for their manufacture
GB1268951A (en) Phenoxy-amines
JPS5277073A (en) 1-carbamoyl-5-fluorouracil deruvative and anticancer drug containing s ame as effective component
GB1394568A (en) Diazepine derivatives and process for the production thereof
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
GB1290841A (cg-RX-API-DMAC7.html)
GB1449070A (en) Aminotetralins and use in inducing anesthesia
JPS5283356A (en) Pharmaceutical composition novel compound containing therein and process for preparing same
GB1324579A (en) N-substituted 3-aminoalkoxy-6-hydrazinopyridazines having antihypertensive activity and their preparation
GB1468079A (en) Ethanolamine derivatives
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
GB1355033A (en) Antimalarial medicines comprising thiazolyl thioureas
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
GB1313274A (en) Bicycloalkanecarboxymides and the preparation thereof
IL53549A (en) Process for the preparation of 1-aziridine-carboxylic acid ester derivatives,pharmaceutical compositions containing the same and certain such novel compounds
IE36065B1 (en) Alkyl sulfonic acid esters of 1,3,2-oxazaphosphacyclic compounds
IL39088A (en) Pharmaceutical hypoglycemic compositions containing picolinic acid derivatives for inhibiting gluconeogenesis
GB1277993A (en) Amebicidal compositions and processes
GB1355689A (en) Piperidylfuranones
GB1367678A (en) Substituted phenyl aminoethanols
GB1268747A (en) Novel 2-naphthyl-2-hydroxy-acetamidine derivatives, their preparation and use
GB1329130A (en) Isoindolo 1,2-b benzothiazol-11 -4bh- one 5-oxides

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees